UTHR logo

UTHRUnited Therapeutics Corp

$541.35
$6.34
(1.16%)
Pre-Market
Updated: 04:01 AM EDT·Prev Close $547.69
Reported EarningsMay 6
Mkt Cap$23.25B
Vol1.00
News
all
press releases
SDZNY or UTHR: Which Is the Better Value Stock Right Now?
SDZNY vs. UTHR: Which Stock Is the Better Value Option?
Zacks
News Placeholder
More News
News Placeholder
United Therapeutics Corporation (UTHR): Renaissance Technologies Likes This Biotech Stock
United Therapeutics Corporation (UTHR): Renaissance Technologies Likes This Biotech Stock...
Yahoo! Finance: News
News Placeholder
United Therapeutics Corporation to Present at the Jefferies Global Healthcare Conference
United Therapeutics Corporation (Nasdaq: UTHR) announced today that James Edgemond, Chief Financial Officer and Treasurer, will provide a company overview and update on Wednesday, June 3, 2026, from 12:45 to 1:15 p.m. EST, at the Jefferies Global Healthcare Conference in New York. The presentation...
Business Wire
News Placeholder
UTHR Holds As Tyvaso Shows 33% Lower Worsening Risk In Rare Lung Scarring Disease
UTHR Holds As Tyvaso Shows 33% Lower Worsening Risk In Rare Lung Scarring Disease
Stocktwits
News Placeholder
United Therapeutics Corporation Announces TETON-1 Study of Tyvaso Published in The New England Journal of Medicine and Presented at ATS 2026
United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced that the New England Journal of Medicine has published the full results of its TETON-1 study, as well as...
Business Wire
News Placeholder
Baidu, Brady And 3 Stocks To Watch Heading Into Monday
U.S. stock futures down on Monday. Focus on Baidu, Brady, United Therapeutics for earnings. XP and Ryanair to report after markets close.read more...
Benzinga
News Placeholder
United Therapeutics Corporation Announces ADVANCE OUTCOMES Study of Ralinepag Presented at ATS 2026
United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced that full results of its ADVANCE OUTCOMES study are being presented today during the Breaking News: 2026...
Business Wire
News Placeholder
United Therapeutics Corporation Announces FDA Clearance to Proceed with UHeart Xenotransplantation Clinical Trial
United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced that the U.S. Food and Drug Administration (FDA) has granted clearance under the companys Investigational...
Business Wire
News Placeholder
CPRX or UTHR: Which Is the Better Value Stock Right Now?
CPRX vs. UTHR: Which Stock Is the Better Value Option?
Zacks
News Placeholder
Varda Space Industries and United Therapeutics Collaborate to Advance Microgravity-Enabled Treatments for Rare Pulmonary Disease
Varda Space Industries and United Therapeutics Collaborate to Advance Microgravity-Enabled Treatments for Rare Pulmonary Disease Varda Space Industries and United Therapeutics Collaborate to Advance...
PR Newswire
<
1
2
...
>

Advertisement|Remove ads.